(Q48126437)
Statements
1 reference
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer (English)
1 reference
J S Chen
1 reference
C Hsu
1 reference
N J Chiang
1 reference
C S Tsai
1 reference
H H Tsou
1 reference
S F Huang
1 reference
L Y Bai
1 reference
I C Chang
1 reference
H S Shiah
1 reference
C L Ho
1 reference
C J Yen
1 reference
K D Lee
1 reference
C F Chiu
1 reference
K M Rau
1 reference
M S Yu
1 reference
Y Yang
1 reference
R K Hsieh
1 reference
J Y Chang
1 reference
Y S Shan
1 reference
Y Chao
1 reference
L T Chen
1 reference
Taiwan Cooperative Oncology Group
1 reference
28 January 2015
1 reference
26
1 reference
5
1 reference
943-949
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference